These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 32960928)
21. The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates. Lee J; Oh CE; Choi EH; Lee HJ Int J Infect Dis; 2013 Aug; 17(8):e638-43. PubMed ID: 23523562 [TBL] [Abstract][Full Text] [Related]
22. Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae. Oliva A; Gizzi F; Mascellino MT; Cipolla A; D'Abramo A; D'Agostino C; Trinchieri V; Russo G; Tierno F; Iannetta M; Mastroianni CM; Vullo V Clin Microbiol Infect; 2016 Feb; 22(2):147-153. PubMed ID: 26409059 [TBL] [Abstract][Full Text] [Related]
23. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model. Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233 [TBL] [Abstract][Full Text] [Related]
25. Activity of temocillin and comparators against urinary Escherichia coli and Klebsiella pneumoniae from Iran. Rahbar M; Van de Velde S; Eslami P; Mardani M Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1793-1796. PubMed ID: 32333223 [TBL] [Abstract][Full Text] [Related]
26. Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987156 [TBL] [Abstract][Full Text] [Related]
27. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. Roy S; Datta S; Viswanathan R; Singh AK; Basu S J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112 [TBL] [Abstract][Full Text] [Related]
28. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital. Basak S; Mallick SK; Bose S J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468 [TBL] [Abstract][Full Text] [Related]
29. Trends in antibiotic susceptibility and incidence of late-onset Klebsiella pneumoniae neonatal sepsis over a six-year period in a neonatal intensive care unit in Karachi, Pakistan. Saleem AF; Qamar FN; Shahzad H; Qadir M; Zaidi AK Int J Infect Dis; 2013 Nov; 17(11):e961-5. PubMed ID: 23759260 [TBL] [Abstract][Full Text] [Related]
31. Study of Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260 [No Abstract] [Full Text] [Related]
32. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella. Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H mBio; 2017 Sep; 8(5):. PubMed ID: 28874470 [No Abstract] [Full Text] [Related]
37. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055 [TBL] [Abstract][Full Text] [Related]
38. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. Hirsch EB; Tam VH J Antimicrob Chemother; 2010 Jun; 65(6):1119-25. PubMed ID: 20378670 [TBL] [Abstract][Full Text] [Related]
39. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data. Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741 [TBL] [Abstract][Full Text] [Related]
40. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China. Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]